ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,185Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 2456

$1.35M Total Retail Price of All Prescriptions

Rank: 17 out of 2456

479 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 479 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 479 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 17,551 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
AMLODIPINE BESYLATE 734 698 1 5
OMEPRAZOLE 681 580 2 3
LISINOPRIL 599 503 3 1
SIMVASTATIN 551 503 4 2
ATORVASTATIN CALCIUM 489 477 5 12
FUROSEMIDE 427 387 6 8
HYDROCHLOROTHIAZIDE 416 395 7 7
ATENOLOL 413 387 8 6
METOPROLOL SUCCINATE 405 384 9 13
METFORMIN HCL 397 355 10 11
ZOLPIDEM TARTRATE 353 348 11 28
METOPROLOL TARTRATE 339 297 12 10
TRAMADOL HCL 336 281 13 24
CRESTOR 328 321 14 25
DIOVAN 292 280 15 26
WARFARIN SODIUM 282 224 16 9
LIDODERM 257 246 17 58
LEVOTHYROXINE SODIUM 252 230 18 4
CLOZAPINE 252 198 18 75
AZOR 234 224 20 320
TAMSULOSIN HCL 218 217 21 32
LOVAZA 207 201 22 219
BENICAR 205 184 23 160
ISOSORBIDE MONONITRATE ER 199 195 24 48
NEXIUM 181 178 25 80
TRAZODONE HCL 164 125 26 17
LIPITOR 162 162 27 63
GABAPENTIN 158 130 28 16
EVISTA 157 134 29 143
NITROSTAT 154 148 30 169
DONEPEZIL HCL 154 154 30 23
BYSTOLIC 141 138 32 234
RISPERIDONE 139 75 33 50
SERTRALINE HCL 134 128 34 21
SYNTHROID 130 111 35 118
ALLOPURINOL 128 122 36 27
PANTOPRAZOLE SODIUM 125 125 37 37
PLAVIX 125 117 37 79
SPIRIVA 125 93 37 43
OLANZAPINE 125 72 37 57
BENZTROPINE MESYLATE 124 79 R 41 126
DIOVAN HCT 123 123 42 139
CITALOPRAM HBR 122 95 43 14
PROAIR HFA 119 63 44 22
MIRTAZAPINE 119 106 44 29
FINASTERIDE 118 118 46 66
BENICAR HCT 115 103 47 267
NAPROXEN 115 104 47 109
ACETAMINOPHEN-CODEINE 107 93 S3 49 106
LACTULOSE 105 69 50 88
CLOPIDOGREL 103 97 51 55
POTASSIUM CHLORIDE 103 94 51 33
TRICOR 102 79 53 163
NIFEDIPINE ER 101 96 54 61
RANITIDINE HCL 96 78 55 31
SOLARAZE 91 79 56 264
CYMBALTA 91 67 56 65
EXELON 91 90 56 161
GLIMEPIRIDE 87 81 59 74
COLCRYS 86 57 60 171
IBUPROFEN 86 65 60 52
VOLTAREN 85 80 62 241
HYDROCORTISONE 85 80 62 234
DIVALPROEX SODIUM 84 49 64 51
QUETIAPINE FUMARATE 81 54 65 47
MECLIZINE HCL 81 80 65 107
ACTONEL 80 80 67 252
NAMENDA 80 80 67 42
DILTIAZEM 24HR CD 79 63 69 113
TOPROL XL 73 73 70 368
AZITHROMYCIN 73 59 70 60
LEVETIRACETAM 73 49 70 90
DOXAZOSIN MESYLATE 72 72 73 71
MUPIROCIN 71 64 74 209
AMITIZA 67 66 75 336
FLUTICASONE PROPIONATE 66 47 76 30
HALOPERIDOL 65 52 77 137
FLUOXETINE HCL 63 39 78 45
LEVOFLOXACIN 63 50 78 103
JANUVIA 62 48 80 81
POLYETHYLENE GLYCOL 3350 62 55 80 64
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 57 80 41
LUMIGAN 61 49 83 362
BUPROPION HCL SR 61 24 83 119
VYTORIN 60 60 85 309
PROCTOZONE-HC 57 52 86 341
IBANDRONATE SODIUM 55 53 87 341
AMLODIPINE BESYLATE-BENAZEPRIL 55 55 87 144
SEROQUEL 55 34 87 102
ALENDRONATE SODIUM 53 49 90 19
PERPHENAZINE 52 26 91 306
DEXILANT 52 51 91 114
LITHIUM CARBONATE 52 12 91 185
GLIPIZIDE 52 52 91 46
ZOVIRAX 50 50 95 382
VESICARE 50 48 95 205
NYSTATIN 50 36 95 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.